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Abstract
International collaboration in spinal cord injury (SCI) research is necessary to overcome the challenges often encountered by
clinicians and researchers, including participant recruitment, high cost, and the need for specialized expertise. However, inter-
national collaboration poses its own obstacles. The objective of this study was to conduct an international online survey to assess
barriers and facilitators to international SCI clinical research, potential initiatives to facilitate future collaborations, and the use of
SCI-specific data sets and standards. Results were analyzed using descriptive statistics. Of 364 total respondents, 213 completed
the survey,with themajority of these participants based inNorthAmerica (38%),Asia (22%), Europe (18%), andOceania (16%).
Over half hadmore than 10 years of experience in SCI research or clinical practice (57%) and 60% had previous experience with
international collaborations. Funding was identified as a top barrier (82%), a facilitator (93%), and a proposed future initiative
(97%). Communication and technology were also identified as strong facilitators and proposed future initiatives. The Interna-
tional Standards forNeurological Classification of SCIwere usedby69%ofparticipants, the International Standards to document
remaining Autonomic Function after SCI by 13% of participants, and the International SCI Data Sets by 45% of participants. As
the need for international collaborations in SCI research increases, it is important to identify how clinicians and researchers can be
supported by SCI consumer and professional organizations, funders, and networks. Furthermore, unique solutions to overcome
modifiable barriers and creation of new facilitators are also needed.
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Introduction
Clinical research in a health condition such as spinal cordinjury (SCI) can be challenging.1,2 The lower incidence and
prevalence of SCI, compared with other major health conditions
such as stroke or cancer, poses inherent challenges to participant
recruitment.3,4 In addition, the cost of conducting clinical studies is
high and the expertise required to execute them is highly specialized.
These challenges often result in small study samples with low sta-
tistical power, increased competition for limited funding, and mul-
tiple studies targeting a small population of individuals with SCI. To
overcome these problems, international collaboration is emerging as
a critical factor to leverage existing funding, personnel, and study
participants. International collaborations also provide an opportunity
to exchange knowledge and experience, improve the generalizability
of research to an international setting, and train the next generation of
clinical researchers.
The International Spinal Cord Society (ISCoS) has a mandate
to promote the highest standard of care in the practice of SCI and
to foster education, research, and clinical excellence.5 The annual
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scientific meetings of ISCoS have provided a venue for clinicians and
researchers from across the world to explore the feasibility and lo-
gistics of expanding international collaborations in clinical research
and best practice implementation. Through ISCoS, there have been
multiple collaborations, such as the ‘‘E-Learning’’ training modules,
which were developed and deployed with input from more than 36
countries and 332 SCI experts worldwide.6 In addition, national and
local SCI networks also are expanding beyond their native country
and forming successful collaborations. Examples of SCI clinical and
research networks around the world include Europe (e.g., European
Multicenter Study about SCI7,8), North America (e.g., Rick Hansen
Institute,9 Ontario Neurotrauma Foundation,10 Spinal Cord Injury
Model Systems11), Australia (e.g., Spinal Research Institute,12 Aus-
tralasian Spinal Cord Injury Network13), and Asia (e.g., ISCoS Da-
tabase: Asian Spinal Cord Network Pilot Project14). There are also a
number of organizations that fund SCI research and have interna-
tional collaborations including: the Christopher and Dana Reeve
Foundation,15 the Craig H. Neilsen Foundation,16 the Miami Project
to Cure Paralysis,17 and the Institute for Safety, Compensation and
Recovery Research.18 Other initiatives working towards international
data standardization and harmonization include the International SCI
Data Sets,19,20 and the National Institute of Neurological Disorders
and Stroke SCI Common Data Elements.21–23
It is evident that, alongwith benefits, international collaborations
pose unique challenges. Cultural and language barriers may hinder
effective communication among team members, ethical complica-
tions with security and privacy for sharing data may arise, and
technical resources for international communication must be pro-
vided. Addressing these potential challenges, or at least considering
them in the planning stage, is crucial for projects to be successful.
In 2013, at the 52nd ISCoS Annual Scientific Meeting in Istanbul,
Turkey, aworkshopwas held to share experiences and lessons learned
from leading international multi-center trials and collaborations, as
well as to discuss the benefits and barriers to participation in inter-
national collaborations in SCI clinical research. The workshop fea-
tured presentations on successful international collaborations from the
perspective of researchers, clinicians, and consumers followed by
small group discussions, and endedwith a panel discussion.As a result
of the workshop, two surveys—one directed to individuals with SCI
(consumer survey) and the other to SCI clinicians and researchers—
were proposed to gain further insights into what individuals perceived
as the prominent facilitators and barriers to participating in interna-
tional collaborations in SCI clinical research. The consumer survey
included 802 participants; the number one facilitator for participating
in clinical research was the possibility of improving functionality and
the number one barrier was the possibility of a decline in function-
ality.24 While these results may have been expected, the unexpected
facilitators and barriers that emerged from the survey include the
possibility to learn more about their general health/SCI and potential
out-of-pocket expenses, respectively.24 The main goal of performing
these surveys was to determine how SCI consumers, researchers, and
organizations can work together to best support, design and conduct
international SCI clinical research collaborations. The objective of the
present article is to describe the results from a survey completed by
clinicians and researchers on the barriers and facilitators to interna-
tional collaborations in SCI clinical research.
Methods
Survey development
The ISCoS 2013 workshop identified the following key
themes for international collaboration: 1) breaking down fund-
ing barriers; 2) improving communication and transparency; and
3) finding future innovative solutions for collaborations. Using
these key themes, expert input, and a literature review of rele-
vant studies, the authors developed a 50-question survey. The
survey consisted of five parts: 1) current barriers to international
collaboration; 2) current facilitators of international collabora-
tion; 3) proposed initiatives to facilitate future international
collaboration; 4) SCI-specific international standards and data
sets; and 5) demographics and expertise of the participant. (For
the complete survey, see the online Supplementary Material at
www.liebertpub.com). Parts 1, 2, and 3 included questions with
five response options that ranged from ‘‘strongly agree’’ to ‘‘strongly
disagree.’’ Participants who identified as having no experience with
international collaborations were directed to skip part 1. Parts 4 and
5 of the survey included questions regarding the participants’ use of
the International SCI Standards and Data Sets and about their ed-
ucational and research/clinical background, respectively. Many
questions included a comments box for free text. The survey was
tested for clarity by members of the research team. Three indi-
viduals with varying amounts of international expertise in con-
ducting SCI research also piloted the survey and provided
feedback.
Participants
Individuals were eligible to participate in the survey if they
fulfilled the following inclusion criteria: 1) were 18 years or older at
the time the survey was conducted; 2) had worked in either SCI
clinical practice or SCI research; and 3) understood written En-
glish. Respondents were recruited through email invitations and
newsletters sent to members, subscribers, collaborators and part-
ners of various SCI organizations (e.g., Rick Hansen Institute;
Ontario Neurotrauma Foundation; Institute for Safety, Compen-
sation and Recovery Research; ISCoS). Flyers advertising the
survey were also distributed at relevant conferences. Participants
were offered the chance to be included in a draw for three $25.00
(CAD) gift certificates if they completed the survey. Ethical ap-
proval to conduct this study was obtained from the Veritas In-
dependent Review Board.25
Data collection
Data collection was performed by the Mustel Group,26 a market
research organization that specializes in online surveys. The survey
data were collected using a web-based format. Materials were
available in English. Demographic information and expertise (both
with SCI and international collaborations) were monitored in an
attempt to minimize any sampling biases and ensure representation
from diverse backgrounds and regions.
Analysis
Data from the survey were analyzed using descriptive statistics.
The top barriers, facilitators and initiatives were determined by
adding together the percentage of participants who ‘‘somewhat
agree’’ and ‘‘strongly agree.’’ Barriers that were potentially mod-
ifiable by an international initiative (e.g., a new funding opportu-
nity), in contrast to a barrier that is specific to a particular country
(e.g., language, privacy regulations) and cannot be easily influ-
enced by an international initiative from an external organization,
were identified by the authors. The comments in parts 1, 2, and 3
were reviewed for each question. The comments in part 4 de-
scribing why participants did not use the International SCI Data
Sets or Standards were grouped into the following categories: in-
accessibility, capacity (e.g., personnel/funding/time constraints),
lack of knowledge/training, unmet research needs, lack of oppor-
tunity, not relevant to their type of research, not part of their role in
the study, unnecessary for their study, and ‘‘other.’’ The countries
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of residence of the participants were grouped into the following
geographical regions: Africa, Asia, Europe, North America, South
America, and Oceania.
Results
Participant demographics
The survey was completed by 213 (referred to as ‘‘participants’’)
out of 364 total respondents who attempted the survey (59%) be-
tween June 2014 and February 2015. For the 151 respondents who
were excluded, 114 (76%) did not complete the survey, 30 (20%)
were ineligible, and seven (< 5%) were duplicates. Participation was
geographically diverse, with the majority from North America
(38%), Asia (22%), Europe (18%), and Oceania (16%). Over half of
the participants (57%) had more than 10 years of experience in SCI
research and/or clinical practice and 60% had previous international
collaboration experience. The majority of participants identified
clinical rehabilitation as one of their areas of research focus (80%)
followed by clinical acute (35%). The most common organizational
research environment was hospital rehabilitation (62%) followed by
academic (58%; Table 1).
Barriers, facilitators and initiatives
Results from part 1 of the survey, completed by 127 participants
with previous international collaboration experience, indicated the
most frequent barriers to international collaborations were funding
availability (82% agreed) followed by insufficient time to dedicate
to research (73%), funding timelines (67%) and differences in
standards of care/health care system differences (67%; Fig. 1). The
importance of funding was reiterated many times in the comments;
for example, ‘‘Start-up of collaborative projects is very expensive
and public funding/granting agencies do not fund the real cost of
initiating collaborative studies,’’ ‘‘[It is] difficult to assign per-
sonnel if you don’t have sustainable funding,’’ and ‘‘[Insufficient
time to dedicate to the project] is not a problem if there is enough
money.’’ Of the 16 barriers included, seven were identified as being
potentially modifiable and could be addressed in a future interna-
tional initiative led by SCI organizations (funding availability;
insufficient time to dedicate to the project/collaboration; funding
timelines; research capacity; study participant recruitment; tech-
nological infrastructure; and knowledge and experience of con-
ducting clinical trials). All seven of the modifiable barriers were
identified in the top 10 barriers to international collaborations.
The majority of responses (> 75%) from the 213 participants in
part 2 of the survey agreed that all six of the suggested factors
influencing participation have facilitated or could facilitate in-
ternational SCI research collaborations (Fig. 2). The paucity of
current facilitators was reflected by the comment of one partici-
pant who noted that, ‘‘in my opinion, the lack of facilitators is a
bigger barrier than any of the barriers listed in this study.’’ Top
facilitators were personal relationships (94% agreed), funding
that can be used to support international research (93%), and
networks (90%).
Similarly to the responses about the facilitators, the majority
of participants (> 75%) agreed that all the proposed future ini-
tiatives would also facilitate international SCI research collab-
orations (Fig. 3). The initiative that most participants agreed
would facilitate future collaborations was additional interna-
tional funding sources (97% agreed). More opportunities to
develop personal relationships (93%) and participate in inter-
national research exchanges specific for SCI (91%) as well as
technology-related factors including a database of available
clinical trials or studies that require additional sites (91%), and
an international information technology platform for data col-
lection and management (90%) were identified. Other ideas
provided by the participants of future initiatives to facilitate in-
ternational collaboration included ‘‘workshops on how it works,
successful examples, and what one would have to do to suc-
cessfully conduct an international research collaboration,’’ and
‘‘organizing small groups with common interests and goals and
providing funding for group collaboration, communication and
exchange is a necessary first step for development of collabo-
rative research teams.’’
International SCI Standards and Data Sets
The International Standards for Neurological Classification of
SCI (ISNCSCI) were reported to be used by 69% of participants
Table 1. Description of Included Participants
Variable Description Value (n= 213)
Level of experience
with international
collaborations
Very experienced 36 (17%)
Some experience 91 (43%)
None 86 (40%)
Highest level of
education*
Diploma 12 (6%)
Bachelor or
undergraduate degree
29 (14%)
Degree in medicine 71 (35%)
Masters 58 (28%)
Doctorate 72 (35%)
Other 27 (13%)
Country of residence
by region
North America 81 (38%)
Asia 46 (22%)
Europe 39 (18%)
Oceania 33 (16%)
Africa 11 (5%)
South America 2 (< 1%)
Missing 1 (< 1%)
Years of experience
in SCI research
and/or clinical
practice
0 to <2 13 (6%)
2 to <5 29 (14%)
5 to 10 50 (23%)
> 10 121 (57%)
Primary research
area*
Pre-clinical 20 (10%)
Clinical (patient-
focused) - acute
71 (35%)
Clinical (patient-
focused) - rehab
163 (80%)
Population (epidemiology) 42 (21%)
Policy (administration) 14 (7%)
Type of
organizational
research
environment*
Academic (affiliated
with a university)
119 (58%)
Industry 12 (6%)
Non-profit 26 (13%)
Hospital—acute 61 (30%)
Hospital—rehabilitation 126 (62%)
Hospital—longer-
term care
24 (12%)
Other 16 (8%)
*Participants can select more than one option.
SCI, spinal cord injury.
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FIG. 1. Barriers to International Spinal Cord Injury Research Collaborations. Barriers are listed by the percentage of participants who
agree.
FIG. 2. Facilitators for International Spinal Cord Injury Research Collaborations. Facilitators are listed by the percentage of par-
ticipants who agree.
FACILITATORS AND BARRIERS TO INTERNATIONAL COLLABORATION 481
(147/213) and the International Standards to document remain-
ing Autonomic Function after SCI (ISAFSCI) by 13% (28/213;
Table 2). Most participants who reported using the ISNCSCI
did so for research and clinical purposes concurrently (46%),
followed by for research purposes only (31%), and for clini-
cal purposes only (22%). Of the 30% of participants (64/213)
who reported not using ISNCSCI or ISAFSCI, more than half
were unaware of the International Standards altogether (55%).
Of the 29 participants who were aware of the standards but did
not use them, the most common reason given (35%) was the
nature of the participants’ work (e.g., ‘‘our work involves evi-
dence syntheses and knowledge translation rather than direct
patient research’’).
The International SCI Data Sets were used by 45% (95/213) of
the participants. Approximately one-third (36%) reported using
the International SCI Data Sets for clinical purposes only, 31%
for research only, and 30% concurrently for research and clinical
purposes. Awareness of International SCI Data Sets among
those currently not using them were similar to that of Interna-
tional Standards, with only 52% (61/118) aware. Again, the most
common reason specified in the comments for not using the
International SCI Data Sets despite being aware of them (18/61,
30%) was because they are beyond the scope of or are not rel-
evant to participants’ current research. For example, ‘‘for ex-
perimental research the International SCI Data Sets is not
always of use.’’
Discussion
This paper describes the results of an international survey that
was conducted to identify the barriers to and facilitators of inter-
national collaborations in SCI clinical research. It was not sur-
prising that funding was recognized as a barrier and a facilitator, as
well as a recommended future initiative.
To our knowledge, this is the first international survey of clin-
icians and researchers in the SCI field to systematically explore the
perceived barriers and facilitators of international collaborations,
even though barriers and facilitators to conducting research in SCI
FIG. 3. Initiatives to facilitate future International Spinal Cord Injury Research Collaborations. Initiatives are listed by the percentage
of participants who agree. IT, information technology.
Table 2. Use of International Spinal Cord
Injury (SCI) Standards and Data Sets
Frequency Percentage
Use of International SCI Standards (n= 213)
Yes - ISNCSCI only 121 57%
Yes - ISAFSCI only 2 1%
Yes - both 26 12%
No 64 30%
Use of ISNCSCI (n= 147)
Research only 46 31%
Clinical only 32 22%
Research and Clinical 67 46%
Research, clinical, and other 1 <1%
Other only 1 <1%
Use of ISAFSCI (n= 28)
Research only 13 46%
Clinical only 8 29%
Research and clinical 6 21%
Other only 1 4%
Aware of International SCI Standards (if do not use them) (n = 64)
Yes 29 45%
No 35 55%
Use of International SCI Data Sets (n = 213)
Yes 95 45%
No 118 55%
How data sets are used
Research only 29 31%
Clinical only 34 36%
Research and clinical 28 30%
Clinical and other 3 3%
Research, clinical and other 1 1%
Aware of data sets (if do not use them) (n = 118)
Yes 61 52%
No 57 48%
ISNCSCI, International Standards for Neurological Classification of
SCI; ISAFSCI, International Standards to document remaining Autonomic
Function after SCI.
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are frequently cited in the literature. For example, the challenges
with the translation of cellular therapies for SCI was explored by an
international group of stakeholders27 and a systematic review of
knowledge translation interventions identified barriers and facili-
tators to implementation.28 Work has also been done to investigate
the state of international collaborations in the area of science and
provide recommendations for supporting collaboration.29,30 From
this survey and from the literature cited above, the theme of funding
appears to be a common challenge.27–30 Additionally, when dis-
cussing barriers to international collaborations in SCI research, it is
also important to keep in mind the challenges faced by prospective
research participants, which include the possibility of decrease in
functionality and out-of-pocket expenses as identified in the con-
sumer survey.24
Encouragingly, seven of the top 10 barriers identified in this
survey are potentially modifiable by an international initiative. In
SCI, there have been recent attempts for funding organizations such
as the Craig H. Nielsen Foundation, Rick Hansen Institute, and
Wings for Life to partner on funding workshops and research
studies. For example, in October 2015, a workshop titled ‘‘Inter-
national Spinal Data Network’’ (ISDN) was held to explore how
SCI registries can partner to align data standards and to share data.
These types of initiatives require funding agencies to address dif-
ferences in their reporting/accountability, areas of priority and
funding timelines. Pilot projects such as the ISDNwill be important
in establishing new precedents on funding international initiatives
and there will also be an opportunity to learn from other organi-
zations, such as the International Initiative for Traumatic Brain
Injury Research.31
Communication- and technology-related factors were also
reported as strong facilitators and initiatives. Factors related to
communication, such as personal relationships, networks, and
research exchanges, were all agreed upon as top facilitators or
initiatives. Specifically, 94% of participants agreed that per-
sonal relationships were a facilitator of international collabo-
rations and 92% agreed that additional opportunities to develop
personal relationships (e.g., mentors) would facilitate future
international collaborations. These relationships are crucial to
finding individuals to collaborate with and to build trust. Si-
milarly, in the consumer survey, recommendation from SCI
peers was identified as a strong facilitator to participation in
clinical research.24 In the present survey, 91% and 90% of
participants agreed that a database of available clinical trials or
studies that require additional sites and an international IT
platform for data collection and management, respectively,
would be initiatives to facilitate future collaborations. Ex-
amples of databases of available clinical trials include the
World Health Organization’s clinical trial registry,32 the Na-
tional Institutes of Health (NIH) World RePORT of funded
research projects33 and ClinicalTrials.gov website,34 and the
Spinal Cord Outcomes Partnership Endeavor’s catalogues of
clinical trials.35 One example of an existing international
electronic data collection platform is the Rick Hansen In-
stitute’s Global Research Platform.36 However, further work is
needed to select (or create) relevant resources and adapt or
expand these for use in international SCI research.
The use of internationally recognized standards was first pro-
posed for the assessment of neurological impairment following
SCI. The first version of the ISNCSCI was released in 1982 and
was most recently revised in 2011.37,38 In the present survey, 69%
of participants reported using the ISNCSCI. Reasons for not using
the ISNCSCI included that the standards were not relevant to the
type of research being conducted or more surprisingly, un-
awareness of the standards. The more recent publication to
document autonomic function (ISAFSCI) was reported to be used
by 13% of participants. Given that the ISAFSCI was first pub-
lished in 2009, it is encouraging to see the initiation of its inter-
national adoption.39
In SCI, the international community has developed data sets to
accompany the recommended standards (ISNCSCI and ISAFSCI).
The first data set, the Core SCI Data Set was published in 2006.40
Development of the data sets was based on the International
Classification of Functioning, Disability, and Health (ICF) frame-
work19 and can include both basic and expanded versions. As per
the ICF, the data sets cover body functions and structures (e.g.,
Lower Urinary Tract and Bowel Basic Data Set), and activities and
participation (e.g., Activities and Participation Basic Data Set).
Thus far, 19 International SCI Basic Data Sets in addition to the
International SCI Core Data Set, as well as a few International SCI
Extended Data Sets, are freely available on the ISCoS website.20,41–43
Participants in this survey identified that these data sets and stan-
dards are an important facilitator (89% agreed) but they are not
fully being utilized, as only 45% of participants reported using
them. However, some participants stated in the comments section
that they did not use them because they were not relevant to the type
of research they conduct. More recently, the requirement by the
NIH and the National Institute of Neurological Disease and Stroke
(NINDS) to use the NINDS SCI Common Data Elements (which
align to the International SCI Data Sets)23 if researchers receive
funding by organizations such as the NIH22 will assist in the im-
plementation of data standards and data sets and accelerate the
sharing of data internationally.
In considering the results from the survey, it is also important
to consider the limitations. Given that the authors were from
Canada, the United States, Europe, and Australia, a large num-
ber of respondents were also from these developed countries.
The authors attempted to recruit from other developing coun-
tries by contacting colleagues working in SCI centres and SCI
organizations but one difficulty was the requirement to read
English. As a result, the study findings may not be generalizable
to developing countries. Additionally, the majority of partici-
pants agreed (> 75%) that all the choices in part 2 (current fa-
cilitators of international collaborations) and part 3 (proposed
initiatives to facilitate collaborations) of the survey were facil-
itators or initiatives that could facilitate international collabo-
rations in SCI research, respectively. This made it difficult to
interpret which facilitators or initiatives were the most impor-
tant. Further, it is difficult to determine a precise response rate as
it was not possible to track all of the persons who were aware of
the survey but did not complete it. Lastly, considering that the
survey was conducted over a span of nine months, we ac-
knowledge the possibility that the institutional affiliations of
participants may have changed following their completion of the
survey.
The need for international collaborations in SCI research is
becoming increasingly evident. Therefore it is important to
identify how clinicians and researchers can be supported by SCI
consumer and professional organizations, funders, and networks
to encourage this type of collaboration. Unique solutions to
overcome modifiable barriers and the creation of new facilitators
to conducting international collaborations are needed, especially
for funding, communication and engagement, and technology.
To do this effectively it will require time and commitment from a
wide range of stakeholders within the SCI community.
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